At the core of this investigation lies the hypothalamic-pituitary-adrenal (HPA) axis, a pivotal neuroendocrine system orchestrating the body’s response to stress through the secretion of glucocorticoids, primarily cortisol. Chronic alterations in the HPA axis output have long been implicated in metabolic dysregulation, immune impairments, hypertension, and, crucially, cardiovascular disease (CVD). Professor Chandola’s team employed hair cortisol measurements—a biomarker providing an integrated window into cumulative cortisol exposure over months—offering an unparalleled lens to capture the enduring effects of psychological stressors tied to specific days of the week.

By harnessing data from the English Longitudinal Study of Ageing (ELSA), encompassing a cohort of over 3,500 older adults, the researchers systematically analyzed self-reported anxiety levels on various weekdays and assessed concurrent biological stress signatures. The results revealed a striking elevation: individuals reporting anxiety specific to Mondays exhibited hair cortisol concentrations approximately 23% higher than those anxious on other days. This sustained hormonal dysregulation was noteworthy not only for its magnitude but also for its persistence, reflecting two months of heightened biological stress exposure, thereby underscoring that Monday-related anxiety imprints a longer-lasting physiological toll than previously recognized.

Importantly, these findings challenge prevailing assumptions that workplace stressors alone drive Monday-specific health risks. Elevated cortisol levels were equally pronounced among retirees—an unexpected outcome that suggests culturally ingrained perceptions of Mondays act as independent stress amplifiers beyond occupational contexts. This notion revolutionizes our understanding of stress epidemiology, emphasizing that societal constructs such as the weekly calendar can shape fundamental biological systems irrespective of an individual’s employment status.

Cardiovascular consequences of such dysregulation are particularly alarming. Previous epidemiological studies have documented a roughly 19% increase in heart attack incidence on Mondays, a phenomenon often attributed to the abrupt transition from weekend rest to workweek demands. Professor Chandola’s study extends this knowledge by identifying HPA-axis dysfunction as a plausible biological bridge linking the psychosocial stress of Mondays to increased CVD risk. This mechanistic insight opens new avenues for targeted interventions aimed at mitigating weekly cyclic stressors to enhance heart health in aging populations.

The study further disentangles the nuances of the “Monday effect.” While heightened anxiety feelings on Mondays contribute to the phenomenon, they account for only a quarter of the observed cortisol elevation. The remaining 75% arises from the greater biological sensitivity to Monday anxiety compared to anxiety experienced on other days. This differentiation highlights a potential sensitization mechanism whereby the body’s stress response is disproportionately amplified at certain culturally significant times, an insight that may have profound implications for chronobiological and psychosocial research fields.

From a neuroendocrine perspective, chronic cortisol elevation disrupts homeostasis by impairing vascular endothelial function, augmenting blood pressure, and promoting insulin resistance and systemic inflammation—all central drivers of atherosclerosis and cardiac events. The HPA axis operates via a finely tuned feedback loop involving hypothalamic corticotropin-releasing hormone (CRH), pituitary adrenocorticotropic hormone (ACTH), and adrenal cortisol secretion. The study’s demonstration of prolonged axis dysregulation linked explicitly to Mondays invites further exploration into whether specific neural substrates—such as limbic system reactivity or circadian modulation—mediate this day-dependent stress amplification.

Technological advances in hair cortisol analysis enabled the research team to integrate psychoendocrinological and epidemiological approaches—a methodological strength that overcomes limitations of single-timepoint cortisol assessments typical of saliva or blood testing. This longitudinal biomarker captures cumulative HPA axis activity, reflecting not momentary spikes but chronic exposure pathways more relevant to disease etiology. In doing so, the study positions itself at the forefront of research exploring the biological embedding of psychosocial stress within aging human populations.

The implications of these findings extend beyond individual health outcomes to societal, cultural, and policy realms. If Mondays act as chronic biological stress amplifiers independent of workplace factors, interventions aiming solely at occupational stress reduction may fall short. Instead, there is a compelling case for public health strategies addressing broader societal stress rhythms, particularly those linked to temporal constructs like weekly cycles. Mindfulness programs, cognitive-behavioral therapies, and societal restructuring of workweek schedules might be avenues to ameliorate these ingrained stress effects.

Professor Chandola’s characterization of Mondays as a “cultural stress amplifier” captures this complex interplay between social norms and physiology. The study underscores that the biological imprint of social timekeeping is not merely metaphorical but consequential, encoded in neuroendocrine function with lasting cardiovascular repercussions. Recognizing and addressing the unique burden of Monday-related stress could ultimately enhance resilience and reduce morbidity in aging populations worldwide.

While future research is warranted to elucidate cellular mechanisms and probe interventions, this study fundamentally reframes how we perceive and approach psychosocial stress. The work prompts a paradigm shift from viewing stress solely as an acute challenge to understanding it as a chronic, culturally mediated biological state with temporal specificity. By highlighting Mondays as a critical node of physiological disruption, it calls for an integration of sociological insights with biomedical sciences to forge innovative pathways toward healthier aging.

The research, funded and conducted within the University of Hong Kong’s Faculty of Social Sciences, stands as a seminal contribution bridging sociology, neuroscience, and health sciences. The revelations carry a message both timely and universal: the start of the week, commonly derided yet little understood biologically, is a potent catalyst of chronic stress with tangible health consequences. Acknowledging and mitigating the “Anxious Monday” effect offers new hope for reducing the global burden of cardiovascular disease within an increasingly aging demographic.

Subject of Research: Not applicable
Article Title: Are anxious Mondays associated with HPA-axis dysregulation? A longitudinal study of older adults in England
News Publication Date: 5-Jun-2025
Web References: http://dx.doi.org/10.1016/j.jad.2025.119611
Image Credits: The University of Hong Kong
Keywords: Life sciences, Neuroscience

Fear extinction—the gradual reduction of a conditioned fear response—is vital for adaptive behavior and mental health. Deficits in this process are implicated in conditions such as PTSD, anxiety disorders, and phobias. While prior studies have identified broad neural circuits involved in fear extinction, the biological factors influencing individual variability remain poorly understood. The study by Ten-Blanco and colleagues addresses this gap by exploring how endocrine, microbial, and genetic factors converge to influence extinction capacity differently across sexes.

Central to their investigation is the hypothalamic-pituitary-adrenal (HPA) axis, a neuroendocrine system that governs stress responses through the release of glucocorticoids like corticosterone in rodents. The authors measured HPA axis activity during fear extinction sessions, revealing that male and female mice exhibit distinct patterns of hormone secretion. These differences corresponded to varying extinction rates, suggesting that the timing and magnitude of corticosterone release modulate how effectively fear memories are diminished.

Beyond hormonal influences, the study harnessed the burgeoning field of microbiome research to examine gut bacterial populations, which have emerged as critical players in brain function via the gut-brain axis. Detailed microbial community profiling revealed sex-specific signatures correlating with fear extinction proficiency. Notably, certain bacterial taxa that produce neuroactive metabolites were more abundant in individuals exhibiting robust extinction, implicating gut microbes as modulators of neural plasticity underlying fear learning.

To deepen the mechanistic understanding, the researchers employed transcriptomic analyses of brain regions implicated in fear processing, such as the amygdala and prefrontal cortex. By sequencing RNA transcripts, they identified gene expression patterns linked to extinction success. Strikingly, gene networks involved in synaptic transmission, neuroinflammation, and stress hormone signaling displayed sex-dependent regulation. This genomic perspective illuminated how males and females mobilize distinct molecular pathways to achieve fear attenuation.

The integrative approach of this study exemplifies modern neuroscience’s shift toward systems biology, where multiple physiological layers are analyzed concurrently to capture the complexity of behavior. By bridging endocrinology, microbiology, and genomics, Ten-Blanco et al. provide a multidimensional map of fear extinction biology. Their findings underscore that any effective therapeutic strategy for anxiety disorders must consider these intertwined factors and sex differences to enhance treatment efficacy.

Moreover, this research highlights the importance of studying both male and female subjects, as most prior fear extinction studies predominantly used male animals, potentially overlooking fundamental sex-specific variables. The documented variations in HPA axis dynamics, microbial composition, and gene expression profiles between sexes contribute to the growing recognition that biological sex profoundly influences brain function and mental health outcomes.

The implications of this work extend into clinical realms. Understanding the mechanisms driving individual differences in fear extinction can inform personalized medicine approaches, including the development of microbiota-targeting interventions or hormone modulation therapies. For example, manipulating gut bacteria through probiotics or diet could offer novel anxiolytic strategies tailored to one’s biological sex and stress hormone profile.

Furthermore, the study opens avenues for biomarker discovery. Molecular signatures uncovered in the transcriptomic data might serve as predictive markers for extinction capacity, which could guide clinicians in identifying patients at risk for chronic fear-related disorders or those likely to respond to cognitive-behavioral therapies that rely on extinction principles.

On a broader scale, the interplay between the HPA axis, gut microbiota, and brain gene expression exemplifies the emerging paradigm of psychoneuroimmunology and neuroendocrinology intersecting with microbial ecology. This holistic view prompts researchers to move beyond reductionist models and appreciate the body’s interconnected systems as dynamic contributors to mental health and disease.

In delineating these biological pathways, the authors also emphasize future directions, suggesting longitudinal studies tracking how these factors evolve across development and in response to environmental challenges. This temporal dimension is crucial as plasticity in stress systems and microbiota composition can profoundly influence lifelong trajectories of emotional regulation.

Technological advances, such as single-cell RNA sequencing and metagenomics, promise to add further granularity by identifying specific cell types involved in fear circuits and pinpointing microbe-host interactions at molecular resolution. Incorporating such methods will refine our understanding of the cellular and microbial actors orchestrating fear extinction.

The interdisciplinary nature of this research spotlights the need for collaborative efforts spanning neuroscience, endocrinology, microbiology, and computational biology. Such synergies will accelerate the translation of basic science findings into clinical applications, ultimately improving outcomes for individuals suffering from debilitating anxiety disorders.

Ten-Blanco et al.’s study stands as a testament to the power of multifaceted inquiry to decode the biological complexity of behavior. By elucidating the sex-specific mechanisms that govern fear extinction through integrated analysis of the HPA axis, gut microbiota, and transcriptomics, they lay a foundation for innovative, personalized treatments that acknowledge individual biological identities.

As anxiety and trauma-related disorders continue to rise globally, insights from this research offer hope for more effective interventions that harness the body’s natural regulatory systems. The convergence of hormonal, microbial, and genetic factors presents a rich tapestry upon which the future of psychiatric neuroscience will be woven, promising breakthroughs that resonate well beyond the laboratory.

Subject of Research: Individual differences in fear extinction mechanisms in male and female mice, focusing on HPA axis function, gut microbiota, and transcriptomic profiles.

Article Title: Exploring individual differences in fear extinction in male and female mice: insights from HPA axis, microbiota, and transcriptomics.

Article References:
Ten-Blanco, M., Ponce-Renilla, M., Pereda-Pérez, I. et al. Exploring individual differences in fear extinction in male and female mice: insights from HPA axis, microbiota, and transcriptomics. Transl Psychiatry 15, 195 (2025). https://doi.org/10.1038/s41398-025-03400-9

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41398-025-03400-9